{"id":50124,"date":"2015-09-30T08:39:19","date_gmt":"2015-09-30T12:39:19","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=50124"},"modified":"2015-09-30T10:41:37","modified_gmt":"2015-09-30T14:41:37","slug":"hedge-fund-manager-again-targets-biogens-ms-drug-patent","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/09\/2015\/hedge-fund-manager-again-targets-biogens-ms-drug-patent.html","title":{"rendered":"Hedge Fund Manager Again Targets Biogen&#8217;s MS Drug Patent"},"content":{"rendered":"<p>(Law360.com) An organization with close ties to hedge fund manager Kyle Bass filed a petition with the Patent Trial and Appeal Board on Monday seeking an inter partes review of Biogen MA Inc.&#8217;s patent covering the multiple sclerosis drug Tecfidera, about a month after the board refused to institute an IPR of the same patent.<\/p>\n<p><a href=\"http:\/\/www.law360.com\/articles\/708681\/hedge-fund-manager-again-targets-biogen-s-ms-drug-patent\">To read this article:<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Law360.com) An organization with close ties to hedge fund manager Kyle Bass filed a petition with the Patent Trial and Appeal Board on Monday seeking an inter partes review of Biogen MA Inc.&#8217;s patent covering the multiple sclerosis drug Tecfidera, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-50124","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/50124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=50124"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/50124\/revisions"}],"predecessor-version":[{"id":50125,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/50124\/revisions\/50125"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=50124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=50124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=50124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}